Salix Pharmaceuticals, Ltd.- Strategy and SWOT Report

MarketLine
December 8, 2011
44 Pages - SKU: MTLN6725734
Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Features:
  • Detailed information on Salix Pharmaceuticals, Ltd. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Salix Pharmaceuticals, Ltd. in the form of a SWOT analysis
  • An in-depth view of the business model of Salix Pharmaceuticals, Ltd. including a breakdown and examination of key business segments
  • Intelligence on Salix Pharmaceuticals, Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Salix Pharmaceuticals, Ltd., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Salix Pharmaceuticals (Salix) is a specialty pharmaceutical company engaged in the development and marketing of prescription pharmaceutical products for the treatment of gastrointestinal diseases. The company's marketed drugs for gastrointestinal disease include Xifaxan, Osmoprep, and Metozolv ODT. It primarily operates in the US. The company is headquartered in Morrisville, North Carolina and employed about 390 people as of December 31, 2010. The company recorded revenues of $337 million during the financial year (FY) ended December 2010, an increase of 44.7% over FY2009. The operating loss of the company was $6.2 million during FY2010, as compared to an operating loss of $40.1 million in FY2009. The net loss was $27.1 million in FY2010, as compared to a net loss of $43.6 million in FY2009.

Reasons to Purchase:
  • Gain understanding of Salix Pharmaceuticals, Ltd. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Salix Pharmaceuticals, Ltd. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Salix Pharmaceuticals, Ltd.’s business structure, strategy and prospects



More Pharmaceuticals Company reports by MarketLine

Argos Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report by MarketLine
Argos Therapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportProject Synopsis:MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...
Mast Therapeutics, Inc. (formerly ADVENTRX Pharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report by MarketLine
Mast Therapeutics, Inc. (formerly ADVENTRX Pharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportProject Synopsis:MarketLine's Company Mergers & Acquisitions (M&A), Partnerships ...
OJSC Pharmstandard – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report by MarketLine
OJSC Pharmstandard – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportProject Synopsis:MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports ...
Ariad Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report by MarketLine
Ariad Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportProject Synopsis:MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 175  
    Global Site License  USD 438  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!